353 related articles for article (PubMed ID: 3020942)
1. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
[TBL] [Abstract][Full Text] [Related]
2. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
3. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
4. Epinephrine potentiates human platelet activation but is not an aggregating agent.
Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
[TBL] [Abstract][Full Text] [Related]
5. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation.
Hikasa Y; Abe M; Satoh T; Hisashi Y; Ogasawara S; Matsuda H
Pharmacology; 1999 Apr; 58(4):171-82. PubMed ID: 10077736
[TBL] [Abstract][Full Text] [Related]
6. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
7. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
8. Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.
Lagarde M; Guichardant M; Ghazi I; Dechavanne M
Prostaglandins; 1980 Apr; 19(4):551-7. PubMed ID: 7384555
[TBL] [Abstract][Full Text] [Related]
9. [Ultrastructural study on the effect of an inhibitor of platelet aggregation (author's transl)].
Le Menn R; Migne J; Probst-Dvojakovic RJ
Arzneimittelforschung; 1979; 29(8a):1278-82. PubMed ID: 540072
[TBL] [Abstract][Full Text] [Related]
10. Platelet functions, alpha 2-adrenergic receptors and cytoplasmic free calcium are normal in the myotonic dystrophy of Steinert.
Lanza F; Cazenave JP; Hemmendinger S; Stierlé A; Tranchant C; Warter JM
J Neurol Sci; 1987 Jun; 79(1-2):13-22. PubMed ID: 3039064
[TBL] [Abstract][Full Text] [Related]
11. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC
Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
13. Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist.
Bolli R; Ware JA; Brandon TA; Weilbaecher DG; Mace ML
J Am Coll Cardiol; 1984 Jun; 3(6):1417-26. PubMed ID: 6715702
[TBL] [Abstract][Full Text] [Related]
14. [Evidence for an alpha 2-blocking property of nicergoline by using antilipolytic alpha-adrenoceptors from adipose tissue].
Carpéné C; Lafontan M; Berlan M
J Pharmacol; 1983; 14(1):57-66. PubMed ID: 6132024
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation. A novel synergism.
Siess W; Lapetina EG
Biochem J; 1989 Oct; 263(2):377-85. PubMed ID: 2574568
[TBL] [Abstract][Full Text] [Related]
16. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
Nunez D; Kumar R; Hanahan DJ
Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069
[TBL] [Abstract][Full Text] [Related]
18. [Ultrastructural study of the action of a blood platelet anti-aggregant. Application to nicergoline].
Le Menn R; Migne J; Prost-Dvojakovic RJ
Therapie; 1977; 32(2):205-14. PubMed ID: 898128
[No Abstract] [Full Text] [Related]
19. Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.
Francesconi M; Scapin M; Casonato A; Girolami A; Deana R
Thromb Res; 2000 Nov; 100(4):293-303. PubMed ID: 11113273
[TBL] [Abstract][Full Text] [Related]
20. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
Jones CR; Pasanisi F; Elliott HL; Reid JL
Br J Clin Pharmacol; 1985 Sep; 20(3):191-6. PubMed ID: 2994701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
